Kidneycancer - kidneycancer.org - Kidney Cancer Association
General Information:
Latest News:
Cerulean Pharma to Present Data on CRLX101's HIF-1a Inhibition at AACR 5 Apr 2013 | 06:22 pm
Dr. Stephen Keefe to present clinical data demonstrating CRLX101's combinability with Avastin® to treat renal cell carcinoma. 04/05/2013
Live! From M. D. Anderson Cancer Center 4 Apr 2013 | 12:16 am
The webcast will focus on case presentations and discussions on localized, locally advanced, and metastatic renal cell carcinoma. The conference is open to all, but is primarily for kidney cancer pati...
Learn About The Judy Nicholson Foundation 3 Apr 2013 | 09:15 pm
The Judy Nicholson Foundation is a charitable foundation established January 2009 after the wife of its founder, Judy Nicholson, passed away after a battle with RCC. The Foundation seeks to raise fund...
Cancer diagnosis inspires actress to create fundraising event for Rouge Valley 3 Apr 2013 | 08:29 pm
One in three Canadian families will be touched by cancer one way or another. Allen-Rowe’s mother died of cervical cancer, and her husband has had kidney cancer. 04/03/2013
Potential biofluid markers and treatment targets for renal cell carcinoma 3 Apr 2013 | 08:26 pm
In this Review, Wettersten and Weiss discuss novel urinary and blood biomarkers and therapeutic targets for renal cell carcinoma, with the hope that dissemination of this information might lead to cli...
Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013 3 Apr 2013 | 08:25 pm
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that two posters related to the Company's microRNA-based diagnostic assays wil...
Survivor Spotlight: Karen Carlier 1 Apr 2013 | 06:45 pm
Everyone goes through a time of panic and fear. Get past that and be optimistic! 04/01/2013
New Market Study Published: Renal Cell Carcinoma - Pipeline Review 1 Apr 2013 | 06:40 pm
Global Markets Direct's, 'Renal Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. 04/01/2013
Vasohibin-1 is a new predictor of disease-free survival 30 Mar 2013 | 05:20 pm
Vasohibin-1 (VASH1) is an endothelium-produced angiogenesis inhibitor. Renal cell carcinoma is highly vascularised, but the significance of endogenous VASH1 in renal cell carcinoma has not been define...
Cancer Drug Kills Every Kind of Tumor: Study 29 Mar 2013 | 04:58 pm
Stanford University scientists have discovered a single drug that has killed or shrunk every kind of cancer tumor it has been used against — a new anti-cancer weapon that some have described as a kind...
